Navigation Links
Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs
Date:8/30/2011

YORK, Pa., Aug. 30, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the development of a unique proprietary range of auto-injectors for the self-administration of injectable drugs by patients outside of healthcare facilities.

Developed for use in conjunction with Unifill prefilled syringes, Unifill Auto-Injectors are compact in size and enable patients to inject a fixed dose of medication with the simple push of a button, without ever seeing the needle. Unlike conventional auto-injector technologies that are used with standard prefilled syringes, the incorporation of the Unifill syringe with its integrated safety features give Unifill Auto-Injectors several significant market advantages including a small diameter, a true end-of-dose indicator and automatic retraction of the needle from the skin after completion of the injection.

Unilife has developed its Unifill Auto-Injectors in single-use disposable and re-usable configurations for use across a wide spectrum of therapeutic drug classes. The Unifill self-injection systems can be customized to support a range of drug viscosities, patient dexterity and visual acuity requirements. Injectable drugs are increasingly supplied in both prefilled syringe and auto-injector formats across a multitude of therapeutic classes. The availability of the Unifill syringe, either in a stand-alone format or supplied together with the Unifill Auto-Injector, can enable pharmaceutical companies to standardize their device platforms under the Unifill technology.

Mr. Alan Shortall, CEO of Unilife, said: "Unifill Auto-Injectors represent a breakthrough technology within the billion dollar market for self-injection systems. Existing auto-injectors in the market use conventional prefilled syringes and can be bulky in size, as they are required to undertake several tasks, includ
'/>"/>

SOURCE Unilife Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Unilife Develops UnifillĀ® EZMix Multiple-Chamber Prefilled Syringes
2. Unilife Signs $10 Million Equipment Financing Agreement
3. Unilife Expands Management Team to Support Business Growth
4. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
5. Unilife Successfully Completes Industrialization of Unifill Syringe
6. Unilife Hosts White House Business Council Meeting
7. Unilife to Present at the 2011 Jefferies Global Healthcare Conference in New York City
8. Unilife to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
9. Unilife Announces Financial Results for the Third Quarter of Fiscal 2011
10. Unilife Corporation to Announce Financial Results for Fiscal 2011 Third Quarter on Monday, May 16, 2011
11. Unilife to Present at the 36th Annual Deutsche Bank Health Care Conference on Monday, May 2, 2011 in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ...
(Date:1/15/2014)... 15, 2014  A novel wearable injector slightly larger than an ... patients to self-inject prescription drugs in the large doses required ... diseases, autoimmune deficiencies, and genetic disorders.  An ... by 2018, according to analysts.   Many of these drugs will ...
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
(Date:4/18/2014)... School of Medicine researchers have been awarded two-year grants ... Nordisk announced this month. Of the 110 initial submissions ... Science Forum Program, only four projects were funded, three ... are Jonathan Powell, M.D., Ph.D.; G. William Wong, Ph.D.; ... a professor of oncology, will use his $500,000 proof ...
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently ... molecule in metastatic breast cancer reduces both the growth ... BRI scientists have found in models of the disease ... - 80 percent and can keep the tumor from ... five-year grant comes from the National Cancer Institute of ...
(Date:4/18/2014)... new study in the American Journal of Preventive ... reveals a recurring pattern that could be leveraged to ... San Diego State University, the Santa Fe Institute, Johns ... searches (searches that included the term healthy and were ... from 2005 to 2012. They found that on average, ...
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... inflammation in non-cancerous prostate tissue may have nearly twice ... with no inflammation, according to results of a new ... Cancer Center. , The link between persistent inflammation and ... prostate cancer those with a Gleason score between ... most aggressive and rapidly growing prostate cancers. , "What ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New research shows people are thinking about their health early in the week 2Health News:New clues on tissue scarring in scleroderma 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3
... Medicine is honored to announce gifts to establish the ... Professorship in Integrative Oncology. This professorship will establish the ... leaders in teaching, research, and patient care in the ... The Parker Foundation and Helen Moss Cancer Research Foundation, ...
... of tuberculosis (TB) in the U.S. is reported as being ... reservoir for disease. Any pool of the world,s population harboring ... vaccine is only 70-80% effective at best. New research published ... , shows that in 2009 the number of cases of ...
... combines two microimaging technologies can reveal both the ... that, in coronary arteries, could indicate the risk ... in arterial stents. In their report receiving ... Hospital (MGH) investigators describe using an intra-arterial catheter ...
... Serena Gordon HealthDay Reporter , SATURDAY, Nov. 5 ... destructive immune response believed to cause lupus, according to new ... One study looked at large doses of vitamin ... vaccine against an immune system protein called interferon alpha. ...
... vasculitis who are in remission, stress can be associated with ... new study by investigators at Hospital for Special Surgery (HSS). ... mental health is a risk factor in patients with vasculitis, ... of blood vessels. The study, in a form of the ...
... 5 (HealthDay News) -- Text message reminders help children -- ... a new study finds. It,s common for youngsters to ... result in poor asthma control. This small pilot study ... or more severe asthma and used inhaled corticosteroids to keep ...
Cached Medicine News:Health News:Pioneering professorship will teach innovative, patient-centered approach to cancer 2Health News:Pioneering professorship will teach innovative, patient-centered approach to cancer 3Health News:Decrease in observed rate of TB at a time of economic recession 2Health News:Combined arterial imaging technology reveals both structural and metabolic details 2Health News: Vitamin D, Interferon Alpha Vaccine Show Promise Against Lupus 2Health News: Vitamin D, Interferon Alpha Vaccine Show Promise Against Lupus 3Health News:Stress triggers disease flares in patients with vasculitis 2Health News:Stress triggers disease flares in patients with vasculitis 3Health News:Text Message Reminders Prompt Kids to Take Asthma Medicine 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: